"
Prevalence of Adverse Drug Reactions to Second Line Anti Tuberculosis Drugs in Nigeria: A Cross-Sectional Study"
written by Abideen Adedayo Ganiyu, Yohanna Kambai Avong, Akinwumi Akinyede, Olusoji Mayowa Ige, Osman El tayeb, Fatai Taleatu, Ayobami Omayeka, Victor Babawale, Ibrahim Oreagba,
published by
Journal of Tuberculosis Research,
Vol.9 No.2, 2021
has been cited by the following article(s):
|
[1]
|
Incidence of adverse drug reactions among tuberculosis patients initiated on daily drug regimen in a southern district of Karnataka
Perspectives in Clinical Research,
2024
DOI:10.4103/picr.picr_20_24
|
|
|
|
|
[2]
|
Incidence, types and predictors of adverse events and their impact on treatment outcomes in multidrug/rifampicin resistant tuberculosis patients receiving all oral treatment regimens
Journal of Evaluation in Clinical Practice,
2024
DOI:10.1111/jep.14230
|
|
|
|
|
[3]
|
Adverse drug reactions and associated factors in multidrug-resistant tuberculosis: A retrospective review of patient medical records at Mbarara Regional Referral Hospital, Uganda
SAGE Open Medicine,
2023
DOI:10.1177/20503121231171350
|
|
|
|
|
[4]
|
Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
Frontiers in Pharmacology,
2022
DOI:10.3389/fphar.2022.883483
|
|
|
|
|
[5]
|
The first-line antituberculosis drugs, and their fixed-dose combination induced abnormal sperm morphology and histological lesions in the testicular cells of male mice
Frontiers in Cell and Developmental Biology,
2022
DOI:10.3389/fcell.2022.1023413
|
|
|
|